Due to the essential role of CtsK in bone resorption, CtsK has been pursued as an attractive antiresorptive drug target in treating diseases associated with excessive bone resorption, such as osteoporosis, rheumatoid arthritis and periodontitis (12). This evidence concerns the gene CTSK and periodontitis.